[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"BlogDetail153Info":3,"ProductServiceList":109,"ApplicationsList":337,"BasicInfo":362},{"msg":4,"code":5,"data":6},"操作成功",0,{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":8,"categoryName":9,"title":10,"imgUrl":11,"content":12,"excerpt":13,"publishDate":14,"seoTitle":15,"seoDesc":16,"seoKeywords":17,"createDate":18,"sort":19,"relatedPostIds":20,"firstServiceProductId":21,"secondServiceProductIds":22,"relatedPost":23,"productService":84,"allSecondProductService":98,"twoSecondProductService":106},null,153,"Recombinant Antibody","Antibody Humanization: Strategies and Benefits for Therapeutic Development ","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F08_20260706150059A291.jpg","\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F08_20260706150105A292.jpg\" title=\" therapeutic antibodies, reduced immunogenicity, \" alt=\" therapeutic antibodies, reduced immunogenicity, \" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Antibody humanization is a critical step in therapeutic antibody development, aimed at reducing immunogenicity while preserving binding affinity and specificity. Non-human antibodies, such as murine or rabbit-derived monoclonals, are highly effective for research but can provoke immune responses in patients if used directly as therapeutics. Humanization techniques modify these antibodies to resemble human immunoglobulins while retaining their original antigen recognition, balancing safety and efficacy for clinical use.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Humanization has become standard practice in the development of monoclonal antibodies for oncology, autoimmune disorders, infectious diseases, and other therapeutic areas. By understanding the strategies and benefits of humanization, developers can design antibodies that are safer, more effective, and compatible with long-term patient treatment.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">CDR Grafting: Preserving Antigen Recognition\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">The most common humanization approach is complementarity-determining region (CDR) grafting. This method involves transferring the antigen-binding CDRs from a non-human antibody onto a human immunoglobulin framework. Because the CDRs dictate specificity and binding affinity, careful selection of the recipient framework is essential to maintain functional activity.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Successful CDR grafting requires analyzing structural compatibility and identifying key residues within the framework that support proper CDR conformation. Advanced computational modeling, molecular dynamics simulations, and structural prediction tools are often used to refine grafts, ensuring that the humanized antibody maintains its original binding properties without introducing steric clashes or instability.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Framework Optimization for Stability and Expression\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Framework regions are not merely scaffolding; they influence antibody folding, stability, and expression. In humanization, certain residues in the original framework may be retained if they are critical for maintaining the CDR conformation. Conversely, modifying non-essential residues to match a human germline sequence reduces immunogenic potential.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Optimized frameworks enhance thermostability, solubility, and expression levels, enabling reliable large-scale production. By combining framework optimization with CDR grafting, developers can produce antibodies that are both functionally active and manufacturable at clinical and commercial scales.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Backmutation and Fine-Tuning Affinity\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Sometimes humanization can slightly reduce antigen-binding affinity. To address this, backmutation strategies are employed, where specific non-human residues critical for binding are reintroduced into the humanized antibody. This fine-tuning ensures that the therapeutic maintains its efficacy while minimizing immunogenicity. Iterative cycles of design, modeling, and experimental validation are commonly used to achieve the optimal balance between affinity and human-like properties.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Reducing Immunogenicity and Enhancing Safety\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">The ultimate goal of humanization is to reduce immunogenicity in patients. Non-human sequences are recognized as foreign by the human immune system, potentially triggering anti-drug antibodies (ADAs) that can neutralize the therapeutic or provoke adverse reactions. By aligning the antibody sequence with human germline frameworks, humanized antibodies elicit fewer immune responses, increasing safety and improving clinical success rates.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">In addition to immunogenicity, humanization can improve pharmacokinetics and tissue distribution. Human-like antibodies interact predictably with neonatal Fc receptors (FcRn), enhancing serum half-life and reducing the need for frequent dosing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Applications in Modern Therapeutics\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Humanized antibodies have become a cornerstone of modern biologics. They are widely used in monoclonal antibody therapies for cancer, inflammatory diseases, infectious diseases, and rare genetic disorders. Humanization also supports next-generation formats, including bispecific antibodies, antibody-drug conjugates (ADCs), and Fc-engineered variants, where safety, stability, and predictable immune interactions are crucial for success.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Antibody humanization is a powerful tool for transforming research antibodies into clinically viable therapeutics. Through CDR grafting, framework optimization, and backmutation strategies, developers can reduce immunogenicity, maintain binding affinity, and improve pharmacokinetics. This process underpins the development of safer, more effective monoclonal antibodies that meet the rigorous demands of modern drug development.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\"> \u003C\u002Fspan>\u003Cspan style=\"font-family: Montserrat;\">platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","","2026-02-03 00:00:00","Antibody Humanization Strategies for Therapeutics: Reducing Immunogenicity and Enhancing Efficacy | GenCefe Biotech","Explore antibody humanization techniques and their benefits in reducing immunogenicity, improving pharmacokinetics, and enabling safer, more effective therapeutic antibodies.","antibody humanization, therapeutic antibodies, reduced immunogenicity, CDR grafting, framework optimization, recombinant antibodies, GenCefe Biotech","2026-02-03 17:10:23",8,"150,149,148,147,146",10,"72,73",[24,36,48,60,72],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":25,"categoryName":9,"title":26,"imgUrl":27,"content":28,"excerpt":13,"publishDate":29,"seoTitle":30,"seoDesc":31,"seoKeywords":32,"createDate":33,"sort":34,"relatedPostIds":35,"firstServiceProductId":21,"secondServiceProductIds":22,"relatedPost":7,"productService":7,"allSecondProductService":7,"twoSecondProductService":7},146,"Recombinant Antibodies vs. Hybridoma Antibodies","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F10\u002F2_20260710133233A315.jpg","\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F10\u002F2_20260710133233A316.jpg\" title=\"antibody expression, antibody engineering\" alt=\"antibody expression, antibody engineering\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">For decades, hybridoma technology was the cornerstone of monoclonal antibody production. Although it played an essential role in scientific development, modern research demands higher reproducibility, cleaner production processes, and more flexible antibody engineering. These needs have pushed recombinant antibodies to the forefront. The transition reflects not only technological advancement but also industry-wide expectations for precision, scalability, and complete sequence control.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Consistency and Lot-to-Lot Reproducibility\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Hybridoma-derived antibodies often suffer from genetic drift as the cell line ages. Productivity changes, mutations accumulate, and contamination risks increase. These factors make batch-to-batch consistency difficult to maintain. In contrast, recombinant antibodies are expressed from defined DNA sequences. Once the sequence is established, it remains the reference for every future production cycle. This ensures that each batch maintains identical structure, quality, and functional activity. The scientific community increasingly emphasizes reproducibility, and recombinant antibodies provide the reliability needed for long-term projects, diagnostic assay development, and regulated manufacturing environments.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Engineering Flexibility and Precision Control\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Hybridomas produce antibodies in forms constrained by the immune system, making structural refinement or functional modification difficult. Recombinant production opens the door to highly targeted engineering. Researchers can optimize antigen-binding regions to increase affinity or specificity, redesign Fc domains to modify effector functions or serum half-life, humanize sequences for therapeutic use, or reconstruct antibodies into different structural formats such as Fab, scFv, VHH, and bispecific molecules. This level of precision and freedom creates opportunities for customized solutions across basic research, diagnostics, and drug development—capabilities that traditional hybridoma systems cannot provide.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Eliminating the Limitations of Animal Immunization\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Hybridoma generation depends heavily on immunization outcomes, which vary from animal to animal. The immune response may not target the desired epitope, and the overall timeline is long and difficult to control. Additionally, hybridoma workflows carry risks of contamination and can fail if the hybridoma line becomes unstable. Recombinant antibody discovery bypasses these limitations entirely. Sequences can originate from phage display, deep B-cell sequencing, in silico design, published literature, or rational engineering of known antibodies. This simplifies the workflow, improves predictability, and reduces ethical concerns associated with animal use.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Scalability and Robust Production\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Recombinant expression systems, such as HEK293 and CHO cells, offer predictable, scalable, and well-controlled production environments. When antibody demand increases, expression can be scaled from milligram-level research quantities to gram-level preclinical or industrial volumes without changing the sequence, compromising quality, or risking cell-line instability. This scalability is critical for diagnostic manufacturers, therapeutic developers, and research groups needing consistent supply. Recombinant systems also integrate more smoothly with GMP-like processes, enabling easier transfer into clinical or production-grade facilities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Compatibility with Modern High-Throughput R&D\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Contemporary antibody research often involves parallel screening, rapid prototyping, and iterative engineering. Hybridomas are slow and require significant manual maintenance, which limits throughput. Recombinant production, however, is designed for speed and automation. Expression vectors can be rapidly constructed, and transient expression systems allow researchers to test multiple variants simultaneously. This efficiency makes recombinant antibodies ideal for next-generation sequencing-informed discovery, multi-epitope diagnostic development, and large-scale R&D programs where speed and repeatability are essential.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Applications Where Recombinant Antibodies Have Become Standard\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Recombinant antibodies have already become the norm in several critical fields. In diagnostics, the demand for high reproducibility and regulatory compliance makes defined-sequence antibodies essential. In therapeutic development, all approved monoclonal antibody drugs are recombinant because the platform allows humanization, affinity maturation, and safety engineering. In cell and gene therapy workflows, recombinant antibodies provide the purity and customization needed for vector purification, cell selection, and process monitoring. Even basic research increasingly favors recombinant formats because they reduce variability and improve data reliability.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Although hybridoma technology has contributed significantly to the scientific landscape, its limitations are becoming increasingly clear in the context of modern research and industrial development. Recombinant antibodies offer unmatched consistency, engineering flexibility, scalability, and compatibility with high-throughput methodologies. As scientific standards rise and applications diversify, recombinant antibodies have become the logical and necessary evolution of antibody production.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","2025-12-16 00:00:00","Recombinant vs. Hybridoma Antibodies | Advantages, Consistency & Engineering | GenCefe Biotech","Discover why recombinant antibodies outperform hybridoma antibodies in consistency, engineering flexibility, and scalability. Learn key advantages for research, diagnostics, and therapeutics.","recombinant antibodies, hybridoma antibodies, antibody production, antibody expression, antibody engineering, antibody reproducibility, diagnostic antibodies, monoclonal antibodies, antibody workflow, CHO expression, HEK293 expression","2025-12-16 14:43:29",1,"157,156,155,154,153",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":37,"categoryName":9,"title":38,"imgUrl":39,"content":40,"excerpt":13,"publishDate":41,"seoTitle":42,"seoDesc":43,"seoKeywords":44,"createDate":45,"sort":46,"relatedPostIds":47,"firstServiceProductId":21,"secondServiceProductIds":22,"relatedPost":7,"productService":7,"allSecondProductService":7,"twoSecondProductService":7},147,"From Sequence to Purified Antibody: A Complete Workflow of Recombinant Antibody Expression","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F10\u002F1_20260710133104A313.jpg","\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F10\u002F1_20260710133109A314.jpg\" title=\"gene synthesis, HEK293 expression,\" alt=\"gene synthesis, HEK293 expression,\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Recombinant antibody expression has become the preferred approach for generating monoclonal antibodies with high reproducibility, flexibility, and scalability. Compared with traditional hybridoma-based methods, the recombinant workflow follows a fully defined, sequence-driven process that ensures exceptional consistency and allows extensive engineering options. Understanding this workflow is essential for researchers who rely on high-quality antibodies for diagnostics, therapeutics, or advanced biological studies. This article provides a comprehensive overview—from gene sequence acquisition to the final purified antibody.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cbr\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Sequence Acquisition and Design\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">The starting point of recombinant antibody production is the amino acid or nucleotide sequence of the antibody’s variable and constant regions. Sequences can originate from published antibodies, next-generation sequencing of B cells, phage display selections, hybridoma sequencing, or rational engineering. Once obtained, the sequence is carefully examined for expression efficiency, structural integrity, and potential liabilities. Codon optimization is typically performed to maximize expression in mammalian systems such as HEK293 or CHO cells. During this stage, researchers may also introduce humanization, affinity maturation, Fc engineering, or format conversion. Because the entire downstream workflow depends on this sequence, rigorous in silico design and initial validation are essential.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cbr\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Gene Synthesis and Vector Construction\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Following sequence design, the antibody genes—typically VH and VL regions linked to IgG constant domains—are synthesized using high-fidelity oligonucleotide assembly. Gene synthesis provides complete control, allowing error-free construction and rapid turnaround. Once synthesized, the genes are cloned into appropriate mammalian expression vectors. These vectors often contain strong promoters such as CMV, optimized leader peptides for secretion, and selectable markers. The heavy- and light-chain plasmids can be assembled into dual-expression cassettes or separated into two vectors depending on the production strategy. Vector design affects expression yield, secretion efficiency, and scalability, making this step crucial to the overall workflow.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cbr\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Transient Expression in Mammalian Cells\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Mammalian expression systems, particularly HEK293 and CHO cells, are widely used for recombinant antibody production because they provide correct folding, glycosylation, and post-translational modifications. Transient transfection allows rapid expression without establishing a stable cell line. HEK293 cells are typically preferred for research-scale production due to their robustness and speed, while CHO cells offer greater scalability and more biologically relevant glycosylation for preclinical development. After transfection, cells are cultured in serum-free medium under optimized conditions for several days. During this period, the antibody is secreted into the culture supernatant, enabling easier downstream purification.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cbr\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Antibody Purification and Polishing\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Once sufficient expression is achieved, the culture supernatant is harvested and clarified. Protein A affinity chromatography is the most commonly used method for IgG purification due to its high specificity for Fc regions. The eluted antibody is then subjected to polishing steps such as ion-exchange chromatography, size-exclusion chromatography, or buffer exchange to remove aggregates, host-cell proteins, and residual DNA. The goal of purification is to obtain a monodisperse, high-purity antibody that meets application-specific requirements. Diagnostic applications may demand extremely low endotoxin levels, while therapeutic development requires more stringent purity and consistency criteria.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cbr\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Analytical Characterization and Quality Control\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Quality control ensures the recombinant antibody meets structural and functional expectations. Typical analyses include SDS-PAGE or CE-SDS to verify heavy- and light-chain identity, size-exclusion chromatography to assess aggregation, and LC-MS for intact mass determination. Binding activity is evaluated using ELISA, biolayer interferometry, or surface plasmon resonance. Additional QC parameters—such as glycosylation profiling, endotoxin level, and concentration measurement—are completed depending on regulatory or research needs. Because recombinant antibody production provides complete sequence control, QC typically shows far lower batch variability compared with hybridoma-derived antibodies.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cbr\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Storage, Stability, and Scale-Up Considerations\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Once QC is complete, the antibody is formulated for long-term stability. Common storage buffers include PBS or histidine-based formulations, often with stabilizing agents such as trehalose. Antibodies may be stored at 4°C for short-term use or at −20°C to −80°C for extended storage. When higher quantities are required, the workflow can be seamlessly scaled. Transient expression can be increased from milliliter to liter scale, while stable CHO cell line development enables industrial-grade production for diagnostic or therapeutic manufacturing. The recombinant platform ensures that scaling does not alter the antibody’s structure or performance.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Recombinant antibody expression is a highly controlled, sequence-defined process that provides unmatched consistency, flexibility, and scalability. By understanding each stage—sequence design, gene synthesis, vector construction, transient expression, purification, and QC—researchers can better evaluate the quality of the antibodies they use and make informed decisions about production strategies. As scientific and industrial requirements continue to rise, the ability to produce reproducible, engineered, and application-ready antibodies has made recombinant expression the dominant method in modern biotechnology.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>","2025-12-23 00:00:00","Recombinant Antibody Expression Workflow | Gene-to-Protein Process Explained | GenCefe Biotech","Learn the complete workflow of recombinant antibody expression—from sequence design and cloning to transient expression and purification. Understand key steps for producing high-quality antibodies.","recombinant antibody expression, antibody workflow, gene synthesis, HEK293 expression, CHO expression, antibody purification, transient expression, antibody production process, monoclonal antibody, antibody QC","2025-12-23 14:10:37",2,"156,155,154,153,152",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":49,"categoryName":9,"title":50,"imgUrl":51,"content":52,"excerpt":13,"publishDate":53,"seoTitle":54,"seoDesc":55,"seoKeywords":56,"createDate":57,"sort":58,"relatedPostIds":59,"firstServiceProductId":21,"secondServiceProductIds":22,"relatedPost":7,"productService":7,"allSecondProductService":7,"twoSecondProductService":7},148,"Enhancing Antibody Affinity and Specificity Through VH\u002FVL Engineering","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F03_20260706145031A281.png","\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F03_20260706145037A282.png\" title=\" antibody affinity, antibody specificity\" alt=\" antibody affinity, antibody specificity\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Antibody engineering has transformed the landscape of modern biotechnology, with VH\u002FVL optimization standing at the center of efforts to improve binding affinity, target specificity, and overall molecular stability. The variable heavy (VH) and variable light (VL) domains determine how an antibody recognizes and engages its antigen. By modifying these regions through rational design, structural modeling, or directed evolution, researchers are able to enhance functional performance and expand applications across diagnostics, therapeutics, and advanced research. As recombinant antibody production becomes standard, VH\u002FVL engineering offers a powerful route to obtaining molecules that outperform their natural counterparts.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Understanding the Structural Basis of Antibody Recognition\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Antibody binding is driven primarily by the complementarity-determining regions (CDRs) within the VH and VL domains. These hypervariable loops determine the shape, charge, and hydrophobicity of the paratope, allowing the antibody to recognize specific epitopes on an antigen. The surrounding framework regions serve as the structural scaffold that stabilizes the CDRs. Even small alterations in CDR length, amino acid composition, or loop flexibility can significantly affect affinity. Similarly, adjustments to the framework can influence overall stability, expression levels, and manufacturability. Understanding the structural interplay between CDRs and frameworks is key to guiding successful engineering strategies.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">CDR Optimization for Improved Affinity\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">CDR engineering is one of the most direct approaches for enhancing affinity. Modifying amino acids within CDR1, CDR2, or CDR3 can strengthen hydrogen bonding, hydrophobic interactions, or electrostatic complementarity with the antigen. For example, introducing aromatic residues can increase π-stacking interactions, while adding charged residues can improve contact with complementary surfaces. Structural modeling and computational analysis are often used to predict beneficial mutations. Experimental methods, such as targeted mutagenesis followed by high-throughput screening, further refine the design. By iterating through cycles of mutation and evaluation, antibodies with significantly improved affinity can be generated without altering their antigen specificity.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Framework Engineering for Stability and Developability\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">While CDRs drive antigen recognition, the framework regions ensure that the antibody maintains its correct fold and supports optimal CDR presentation. Engineering the frameworks can enhance thermostability, increase expression levels, reduce aggregation, and improve overall manufacturability. Substituting unstable residues or incorporating consensus framework elements can stabilize the protein. In some cases, grafting CDRs into optimized human frameworks is necessary for humanization or therapeutic development. Framework engineering also helps maintain compatibility between VH and VL domains, ensuring that the antibody assembles correctly and preserves its biological function.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Refining VH\u002FVL Pairing for Improved Binding Behavior\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">The interaction between VH and VL domains significantly influences antibody performance. Even if each domain independently binds the antigen well, their pairing can create unexpected structural constraints or alter the geometry of the binding site. Engineering efforts often examine interface residues that contribute to domain–domain packing. Rational modifications can promote favorable hydrophobic interactions or strengthen hydrogen-bond networks at the interface. Improving VH\u002FVL pairing frequently results in enhanced affinity, greater expression efficiency, and increased antibody stability. In some cases, altering the orientation of the domains can reveal novel binding configurations or broaden epitope recognition.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Applying Computational Tools to Predict High-Performance Designs\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Advances in molecular modeling, AI-based structure prediction, and energy-scoring algorithms have significantly accelerated VH\u002FVL engineering. Computational methods can analyze structural conformations, predict mutation impacts, and identify optimized CDR loop geometries. These tools help narrow down large mutation libraries and prioritize variants with high predicted stability or improved binding energy. Structural databases and machine-learning models trained on antibody–antigen complexes further assist in designing variants that maintain specificity while enhancing affinity. By integrating computation with experimental validation, researchers can reduce development time and increase design success.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Directed Evolution to Discover High-Affinity Variants\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">In addition to rational design, directed evolution offers a powerful way to improve antibody affinity by mimicking natural selection. Libraries of VH or VL variants are generated through random mutagenesis or targeted diversification approaches. These libraries are expressed in display systems such as phage, yeast, or mammalian display, where they undergo multiple rounds of antigen binding selection. Variants with the strongest interactions are enriched and further refined. Directed evolution can identify unexpected beneficial mutations that computational analysis might overlook, making it a valuable complement to structure-based engineering.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Balancing Affinity With Developability Requirements\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Although high affinity is often a desired outcome, it is important to ensure that engineered antibodies retain favorable developability properties. Excessively high affinity may reduce dissociation rates, impair epitope accessibility, or interfere with biological mechanisms such as receptor turnover. VH\u002FVL engineering therefore requires careful optimization to balance affinity, specificity, stability, and expression levels. Developability assessments—including aggregation propensity, charge distribution analysis, and thermostability evaluation—ensure that high-affinity antibodies also perform well in manufacturing and downstream applications.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">VH\u002FVL engineering enables the creation of antibodies with optimized affinity, enhanced specificity, and improved structural stability. Through CDR modification, framework optimization, interface engineering, computational modeling, and directed evolution, researchers can reshape antibody properties with remarkable precision. As recombinant antibody technologies advance, VH\u002FVL engineering has become a central strategy in developing next-generation diagnostic antibodies, therapeutic candidates, and research tools capable of meeting increasingly demanding performance standards.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">,\u003C\u002Fspan>\u003Cspan style=\"font-family: Montserrat;\"> as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","2025-12-30 00:00:00","VH\u002FVL Engineering for Antibody Optimization | Affinity & Specificity Improvement | GenCefe Biotech","Discover how VH\u002FVL engineering improves antibody affinity and specificity. Learn key strategies such as CDR optimization, framework engineering, and structural refinement for high-performance recombinant antibodies.","VH VL engineering, antibody affinity, antibody specificity, CDR optimization, antibody engineering, recombinant antibody design, affinity maturation, antibody structure, therapeutic antibody optimization","2025-12-30 13:17:15",3,"155,153,152,151,149",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":61,"categoryName":9,"title":62,"imgUrl":63,"content":64,"excerpt":13,"publishDate":65,"seoTitle":66,"seoDesc":67,"seoKeywords":68,"createDate":69,"sort":70,"relatedPostIds":71,"firstServiceProductId":21,"secondServiceProductIds":22,"relatedPost":7,"productService":7,"allSecondProductService":7,"twoSecondProductService":7},149,"Fc Engineering: Applications and Trends in Antibody Drug Development","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F04_20260706145835A283.png","\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F04_20260706145840A284.png\" title=\"antibody drug development\" alt=\"antibody drug development\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Fc engineering has become an essential pillar in the evolution of antibody therapeutics. As antibody drugs mature beyond simple target binding, the Fc region—once considered merely a structural backbone—has emerged as a powerful design element capable of modulating immune response, pharmacokinetics, tissue distribution, and overall therapeutic behavior. Modern biologics rely not only on the antigen-binding domain but also on the refined functions of the Fc region to achieve enhanced efficacy and safety. As the biopharmaceutical industry moves toward next-generation antibody formats, Fc engineering is reshaping how antibodies are optimized for oncology, autoimmune diseases, infectious diseases, and beyond.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Understanding the Role of the Fc Region\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">The Fc region is responsible for mediating interactions between antibodies and various immune components, including Fcγ receptors, complement proteins, and neonatal Fc receptors (FcRn). These interactions determine whether an antibody primarily triggers cytotoxic immune responses, enhances phagocytosis, or prolongs its presence in circulation. Because each therapeutic antibody may require a specific balance between effector functions and half-life, manipulating the Fc region has become an indispensable strategy for designing precisely tuned biologics.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">In oncology, for example, strong effector functions such as antibody-dependent cellular cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC) are desirable. In contrast, for inflammatory or autoimmune diseases, the optimal therapeutic effect often requires minimizing immune activation to avoid exacerbating disease progression. Understanding these functional contexts is foundational for selecting an Fc engineering strategy.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Enhancing Effector Functions for Targeted Cytotoxicity\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">One of the most widely adopted uses of Fc engineering is enhancing the antibody’s ability to recruit immune cells to eliminate pathogenic targets. By altering Fcγ receptor binding affinities through amino acid substitutions or glyco-engineering, developers can significantly increase ADCC and CDC potency.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">An important example is the optimization of Fc glycan structures. Removing fucose residues (afucosylation) can dramatically improve an antibody’s interaction with FcγRIIIa receptors, resulting in stronger NK-cell–mediated cytotoxic responses. This approach has led to the development of several clinically approved antibodies demonstrating higher tumor-killing efficiency compared with their non-engineered counterparts.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">These engineered enhancements have expanded the potential of monoclonal antibodies in cancer immunotherapy, allowing more precise and powerful targeting of tumor cells without increasing systemic toxicity.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Suppressing Immune Activation for Autoimmune and Chronic Diseases\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">While strengthening immune activation is valuable in oncology, certain therapeutic areas require the opposite outcome. For autoimmune diseases, chronic inflammation, or enzyme replacement therapy, it’s often necessary to reduce effector functions to prevent unintended tissue damage.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">To address this requirement, Fc silencing mutations have been developed to diminish binding to Fcγ receptors and eliminate complement recruitment. By eliminating these interactions, engineered antibodies retain target affinity but minimize immune-mediated side effects. These modifications have directly contributed to the improved tolerability and safety of biologics targeting inflammatory pathways, making them suitable for long-term treatment regimens.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Improving Pharmacokinetics Through FcRn Optimization\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Beyond immune effector regulation, Fc engineering is a powerful method for modulating antibody half-life. Through interactions with FcRn receptors, antibodies can be recycled instead of being degraded, allowing them to remain in circulation for weeks. Consequently, introducing engineered mutations that enhance FcRn binding at acidic pH is a proven way to prolong half-life and reduce dosing frequency.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Such modifications have set new standards for patient compliance by enabling monthly or even quarterly dosing intervals for chronic conditions. As more therapeutics aim for self-administration and long-acting formulations, FcRn-enhancing mutations are becoming increasingly prevalent in drug development pipelines.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Fc Engineering in Emerging Antibody Formats\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Fc engineering is now integrated into many advanced therapeutic platforms, including bispecific antibodies, antibody–drug conjugates (ADCs), and therapeutic fusion proteins. In bispecific formats, Fc modifications help stabilize the molecule, balance arm pairing, and fine-tune immune activation. For ADCs, an optimized Fc region ensures better pharmacokinetics and more reliable trafficking to target tissues.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">With the advancement of AI-assisted protein design and high-throughput screening, Fc engineering is also evolving toward more predictive, data-driven strategies. Machine learning models are increasingly used to identify mutation combinations that enhance stability or modulate immune interactions, accelerating development timelines and increasing success rates.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Future Trends in Fc Engineering\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Research continues to push the boundaries of what the Fc region can achieve. Novel directions include Fc variants designed to localize antibodies to specific tissues, Fc switches that respond to physiological cues, and immune-modulating designs that create more selective or context-dependent effector functions. These emerging technologies reflect a broader shift toward highly customizable antibody platforms, where each functional aspect can be tuned to meet the needs of precision medicine.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">As regulatory agencies and industry stakeholders gain more experience with engineered Fc designs, the adoption of these innovations is expected to accelerate, shaping the next generation of safer, more effective, and more versatile therapeutic antibodies.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>","2026-01-06 00:00:00","Fc Engineering in Antibody Drug Development: Mechanisms, Applications, and Future Trends | GenCefe Biotech","Learn how Fc engineering enhances antibody efficacy, stability, and therapeutic performance, and explore current technologies and trends shaping next-generation antibody therapeutics.","Fc engineering, antibody drug development, Fc region modification, ADCC, CDC, half-life extension, recombinant antibodies, GenCefe Biotech","2026-01-06 14:53:05",4,"156,155,154,152,147",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":73,"categoryName":9,"title":74,"imgUrl":75,"content":76,"excerpt":13,"publishDate":77,"seoTitle":78,"seoDesc":79,"seoKeywords":80,"createDate":81,"sort":82,"relatedPostIds":83,"firstServiceProductId":21,"secondServiceProductIds":22,"relatedPost":7,"productService":7,"allSecondProductService":7,"twoSecondProductService":7},150," Recombinant Antibodies for Diagnostics: Ensuring Consistency and Lot-to-Lot Reproducibility ","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F05_20260706145917A285.png","\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F05_20260706145922A286.png\" title=\"diagnostic antibodies, assay reproducibility,\" alt=\"diagnostic antibodies, assay reproducibility,\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Diagnostic technologies rely heavily on the precision and consistency of antibodies. Whether for immunoassays, lateral-flow tests, biomarker quantification, or clinical screening, the ability of an antibody to bind reliably and reproducibly across batches is a foundational requirement. Traditional hybridoma-derived antibodies, while widely used, inherently carry biological variability that can compromise assay performance over time. Recombinant antibodies, produced through sequence-defined expression systems, have emerged as the gold standard for assays that demand long-term stability and consistency. As diagnostic markets expand and regulatory expectations increase, the advantages offered by recombinant technologies are becoming indispensable.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">The Limitations of Hybridoma-Derived Antibodies\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Hybridoma technology has contributed significantly to antibody research and product development, but its biological nature introduces unpredictability. Hybridoma cells may drift genetically or lose productivity over time, resulting in significant variation between production lots. Even subtle differences in glycosylation, sequence stability, or cell viability can translate into reduced binding affinity, altered specificity, or increased background noise in diagnostic assays. Such inconsistencies become particularly problematic in high-throughput clinical diagnostics, where precision and standardization are essential for reliable decision-making. As global regulatory frameworks tighten around assay reproducibility, reliance on unstable hybridoma lines poses increasing challenges.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">How Recombinant Antibodies Address Variability\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Recombinant antibodies overcome these limitations by anchoring production to a defined DNA sequence rather than a biologically unstable cell line. Once the sequence is identified, cloned, and validated, the antibody can be produced consistently in mammalian, bacterial, or cell-free systems with minimal variability. The expression host, culture conditions, and purification procedures can be standardized and reproduced across batches and facilities. This sequence-based control ensures that diagnostic developers receive identical molecules every time, regardless of scale or timing, eliminating the risk of genetic drift or spontaneous mutation. Such reproducibility significantly enhances product reliability and reduces batch-to-batch troubleshooting.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Stability and Long-Term Supply Assurance\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Many diagnostic assays require stable supply over multiple years, especially when incorporated into commercial diagnostic kits, regulatory submissions, or mass-market clinical tests. A single change in antibody characteristics can necessitate re-validation, leading to costly delays and compliance risks. Recombinant antibody technology directly addresses this concern by enabling unlimited production from a preserved DNA sequence stored under secure and stable conditions. This guarantees continuity of supply even if production facilities change or bioreactors are upgraded. Long-term storage of expression constructs also allows rapid scale-up, ensuring that increasing market demand does not compromise batch uniformity or timeline reliability.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Enhanced Specificity Through Sequence Engineering\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Recombinant antibody platforms also provide the opportunity to refine specificity and affinity through rational sequence engineering. Developers can eliminate cross-reactivity, reduce non-specific binding, or enhance performance under specific assay conditions such as pH constraints or high-salt environments. These improvements are difficult to achieve through hybridoma methods, where antibody optimization relies on biological unpredictability. By contrast, recombinant engineering allows precise control over variable regions, constant regions, and framework stability. The result is a highly tailored molecule that performs consistently in clinical assays, even under stress or in complex matrices such as serum, plasma, or whole blood.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Regulatory Advantages and Quality Control\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">As diagnostic products face increasingly rigorous global regulatory standards, recombinant antibodies offer clear advantages in traceability, documentation, and quality assurance. Because production is sequence-defined, each batch can be validated and documented with precise molecular identity. Regulatory agencies favor such predictability, particularly in assays designed for infectious disease detection, oncology screening, and chronic disease monitoring. Consistent molecular profiles also support manufacturing audits, reduce batch-failure rates, and streamline quality control processes. For companies developing diagnostic assays intended for international markets, recombinant systems provide a robust and compliant pathway to scale.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Future Outlook: Recombinant Antibodies as the New Diagnostic Standard\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">As the diagnostic industry continues to grow, the requirement for long-term reproducibility and global standardization is becoming more critical. Recombinant antibodies are positioned to become the default option for IVD manufacturers, clinical laboratories, and biotech companies seeking dependable and scalable solutions. With advances in sequence optimization, high-throughput screening, and AI-guided antibody engineering, the next wave of diagnostic reagents will increasingly rely on recombinant production. This shift promises a more reliable and sustainable diagnostic ecosystem, enabling faster innovation and more precise clinical decision-making.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>","2026-01-13 00:00:00","Recombinant Antibodies for Diagnostics: Reliability, Consistency, and Lot-to-Lot Stability | GenCefe Biotech","Discover why recombinant antibodies deliver superior consistency, stability, and reproducibility in diagnostic assay development compared to hybridoma-derived antibodies.","recombinant antibodies, diagnostic antibodies, assay reproducibility, lot-to-lot consistency, antibody stability, diagnostics development, GenCefe Biotech","2026-01-13 10:39:00",5,"154,152,149,148,146",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":21,"title":9,"excerpt":13,"content":85,"seoTitle":86,"seoDesc":87,"seoKeywords":88,"sort":89,"createDate":90,"secondColor":91,"showOrderPic":5,"homeState":34,"homePic":92,"homeTitle":9,"homeDesc":93,"homeSort":94,"orderDesc":13,"orderUrl":95,"email":96,"phone":97,"onlineFormUrl":95,"serviceFeatureList":7,"productServiceSubList":7},"\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"font-family: Montserrat; text-decoration: underline;\">\u003Cspan style=\"font-family: Montserrat;\">recombinant antibody production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\"> and protein production. Supported by our well-established gene synthesis platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to antibody and protein purification, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">We offer efficient, stable, and customizable antibody expression solutions for academic institutions and biopharmaceutical companies, enabling smooth transitions from fundamental research to drug development. With our robust technical systems and extensive project experience, GenCefe is committed to accelerating antibody R&D and enhancing translational efficiency for innovative discoveries.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">GenCefe Recombinant Antibody & Protein Solution\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2025\u002F11\u002F20\u002F图片3_20251120164845A006.png\" title=\"\" alt=\"\"\u002F>\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-align:center\">\u003Cbr\u002F>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","Recombinant Antibody | Fast Turnaround from 1 Week-GenCefe","GenCefe provides recombinant antibody expression and purification for antibody development, therapeutic research, antigen binding studies, and immunoassays.","Recombinant Antibody Expression, Recombinant Monoclonal Antibody Expression, Recombinant mAb Production, Custom Recombinant Antibody, Antibody Expression Services",55,"2025-11-20 09:55:49","#185192","https:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2025\u002F11\u002F24\u002F抗体-蓝_20251124160642A001.png","Delivering fast, high-quality recombinant antibody solutions.",60,"https:\u002F\u002Fforms.zohopublic.com\u002Fgencefebiotech1\u002Fform\u002FRecombinantAntibodyQuoteForm\u002Fformperma\u002FuJSYaxh8gmZuKHDp5D3hdXdkonkzBZ6lhYmlygYkmP8","gene@gencefebio.com","+1 408-828-0438",[99,103],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":100,"parentId":21,"title":101,"subTitle":13,"excerpt":13,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":34,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},72,"Recombinant Monoclonal Antibody Services","服务",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":104,"parentId":21,"title":105,"subTitle":13,"excerpt":13,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},73,"Large-Scale Recombinant Antibody\u002FProtein Production",[107,108],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":100,"parentId":21,"title":101,"subTitle":13,"excerpt":13,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":34,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":104,"parentId":21,"title":105,"subTitle":13,"excerpt":13,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},{"msg":4,"code":5,"data":110},[111,149,185,227,238,253,257,279,311,334],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":112,"title":113,"excerpt":7,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"sort":7,"createDate":7,"secondColor":7,"showOrderPic":7,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"serviceFeatureList":7,"productServiceSubList":114},9,"Gene Synthesis and Related Services",[115,120,125,130,135,140,145],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":116,"parentId":112,"title":117,"subTitle":118,"excerpt":119,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":34,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},11,"Gene Synthesis","Custom gene synthesis solutions with optimized design and reliable quality.","GenCefe gene synthesis services - professional technical support, free codon optimization, fast delivery and 100% accuracy guarantee.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":121,"parentId":112,"title":122,"subTitle":123,"excerpt":124,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},12,"Codon Optimization","Host-specific codon optimization to support efficient recombinant protein expression.","GenCefe has introduced advanced AI technology into codon optimization and independently developed the Codon Optimization Tool, which can significantly increase the protein expression level and success rate.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":126,"parentId":112,"title":127,"subTitle":128,"excerpt":129,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},48,"Gene Fragments","Custom DNA fragments for flexible downstream assembly.","GenCefe offers DNA fragment synthesis service with strict QC standards and fast turnaround, saving time and budget for you.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":131,"parentId":112,"title":132,"subTitle":133,"excerpt":134,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},49,"Subcloning & PCR Cloning","Custom Cloning Solutions for Tailored Plasmid Construction","GenCefe Biotech can help customers clone the target gene into any site of the specified vector to meet different needs.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":136,"parentId":112,"title":137,"subTitle":138,"excerpt":139,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},50,"Plasmid Preparation","Flexible plasmid preparation tailored to your specific needs.","GenCefe provides high-quality plasmid preparation from micrograms to grams, with strict QC for batch consistency.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":141,"parentId":112,"title":142,"subTitle":143,"excerpt":144,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},51,"Mutagenesis","Custom DNA mutagenesis for precise sequence modifications.","GenCefe provides various site-directed mutagenesis services,including insertions,deletions,and substitutions,we can precisely introduce mutations into DNA sequences and deliver 100% accuracy sequences",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":146,"parentId":112,"title":147,"subTitle":13,"excerpt":148,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},52,"Gene Synthesis Case Studies","GenCefe's experienced team has successfully delivered various difficult gene sequences, including GC-rich, repeated, ultra-long genes, etc.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":34,"title":150,"excerpt":7,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"sort":7,"createDate":7,"secondColor":7,"showOrderPic":7,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"serviceFeatureList":7,"productServiceSubList":151},"RNAi Products & RNA Synthesis",[152,157,163,168,173,178,181],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":153,"parentId":34,"title":154,"subTitle":155,"excerpt":156,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},13,"Custom siRNA Synthesis","Custom siRNA Synthesis and Modifications for Diverse Research Needs","GenCefe provides siRNA design and custom synthesis, including standard siRNA oligos and modified siRNA oligos, to meet customers'specific needs.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":158,"parentId":34,"title":159,"subTitle":160,"excerpt":161,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":34,"newState":5,"type":162,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},22,"Pre-Designed siRNA Sets","Ready-to-Order siRNA Sets for Targeted Gene-Silencing Research","GenCefe Biotech provides 50,000+ pre-designed siRNA sets for human, rat, and mouse. Guaranteed gene silencing, free control siRNA.","产品",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":164,"parentId":34,"title":165,"subTitle":166,"excerpt":167,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},56,"Custom miRNA Mimic\u002FInhibitor","Custom miRNA Mimics and Inhibitors for In Vitro and In Vivo Research","GenCefe has developed various miRNA mimics for gain-of-function studies and inhibitors for loss-of-function studies, with different options for both in vitro and in vivo experiments.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":169,"parentId":34,"title":170,"subTitle":171,"excerpt":172,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},58,"sgRNA Synthesis","Custom gRNA Synthesis and Design with Flexible Options and Quality Control","GenCefe provides sgRNA design and chemical synthesis services. Deliverables are tested by mass spectrometry for sequence accuracy and purified by HPLC.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":174,"parentId":34,"title":175,"subTitle":176,"excerpt":177,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":34,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},59,"circRNA","Flexible circRNA Synthesis with Chemical and IVT Platforms.","GenCefe Biotech offers both chemical and IVT synthesis of circRNA, enabling customized solutions with flexible lengths and purity to meet diverse research needs.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":94,"parentId":34,"title":179,"subTitle":13,"excerpt":180,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},"RNA Modifications","GenCefe Biotech provides comprehensive RNA modification, labeling, and conjugation services to meet the needs of different types of nucleic acid drug delivery.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":182,"parentId":34,"title":183,"subTitle":13,"excerpt":184,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},61,"RNA QC Standards","GenCefe Biotech is committed to providing high-quality oligonucleotide products and services; we perform HPLC detection and provide COA files for all of our oligonucleotide products by default. ",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":46,"title":186,"excerpt":7,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"sort":7,"createDate":7,"secondColor":7,"showOrderPic":7,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"serviceFeatureList":7,"productServiceSubList":187},"DNA Oligo Synthesis",[188,193,197,202,206,210,214,219,223],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":189,"parentId":46,"title":190,"subTitle":191,"excerpt":192,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},62,"Custom DNA Oligo Synthesis","Custom DNA Oligo Synthesis with Flexible Specifications and Reliable Quality","GenCefe provides high-quality oligonucleotide synthesis and modification services, including standard primers, qPCR primers and probes, NGS primers, etc. ",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":194,"parentId":46,"title":195,"subTitle":13,"excerpt":196,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},63,"DNA Oligo Modifications","GenCefe provides comprehensive modifications, including biotin, digoxigenin, fluorescence, phosphorylation, phosphorothioates, amino Linkers, etc.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":198,"parentId":46,"title":199,"subTitle":200,"excerpt":201,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},64,"qPCR Primers & Probes","Custom qPCR primers and probes with flexible specifications and reliable quality.","GenCefe Biotech has established an advanced oligo synthesis and modification technology platform with an experienced technical team to provide customized qPCR primers and probes.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":203,"parentId":46,"title":204,"subTitle":13,"excerpt":205,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},65,"NGS Primers & Probes","GenCefe Biotech offers NGS adapters, blockers, capture probes, and multiplex PCR primers using advanced oligo synthesis and modification technology.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":207,"parentId":46,"title":208,"subTitle":13,"excerpt":209,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},66,"FISH Probes","GenCefe Biotech offers custom FISH probe design and synthesis with various fluorescent labels (Cy3, Cy5, FAM), HPLC purification, and expert technical support.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":211,"parentId":46,"title":212,"subTitle":13,"excerpt":213,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},67,"STR Primers"," GenCefe offers high-quality fluorescently labeled STR primers for forensic applications, with optimized dyes, purification processes, and strict quality standards.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":215,"parentId":46,"title":216,"subTitle":217,"excerpt":218,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":34,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},68,"Circular DNA","Custom single-stranded circular DNA synthesis tailored to your research needs. ","GenCefe Biotech has successfully developed single-stranded circular DNA (CssDNA) synthesis technology, providing researchers in gene expression, gene therapy, and vaccine development with a powerful new tool. ",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":220,"parentId":46,"title":221,"subTitle":13,"excerpt":222,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},70,"PCR Assay Design and Development","GenCefe Biotech combines 10+ years oligo synthesis experience with bioinformatics and AI to offer one-step PCR assay design, synthesis, and verification services.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":224,"parentId":46,"title":225,"subTitle":13,"excerpt":226,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},71,"DNA Oligo QC","GenCefe Biotech has a strict ISO9001 & ISO13485-certified QC system for oligos, offering standard and customized QC for research and IVD applications.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":58,"title":228,"excerpt":7,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"sort":7,"createDate":7,"secondColor":7,"showOrderPic":7,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"serviceFeatureList":7,"productServiceSubList":229},"IVT mRNA Synthesis",[230,234],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":231,"parentId":58,"title":232,"subTitle":13,"excerpt":233,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},74,"Custom IVT mRNA Synthesis Services","GenCefe Biotech provides custom IVT mRNA synthesis services for research and therapeutic development.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":235,"parentId":58,"title":236,"subTitle":13,"excerpt":237,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":34,"newState":5,"type":162,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},20,"Off-the-shelf mRNA Products","GenCefe Biotech offers high-quality off-the-shelf products, including mRNA and circRNA, with rigorous QC for purity, activity, and stability—saving you time and costs. ",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":239,"title":240,"excerpt":7,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"sort":7,"createDate":7,"secondColor":7,"showOrderPic":7,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"serviceFeatureList":7,"productServiceSubList":241},6,"CRISPR Cas9",[242,245,249],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":243,"parentId":239,"title":170,"subTitle":13,"excerpt":244,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},34,"GenCefe Biotech provides customizable gRNA synthesis services, including sgRNA for CRISPR-Cas9 applications and pegRNA for precise genome editing and prime editing workflows.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":246,"parentId":239,"title":247,"subTitle":13,"excerpt":248,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},35,"ssDNA Synthesis Services","GenCefe Biotech offers high-purity ssDNA synthesis up to several kilobases, with minimal double-stranded DNA residues, supporting cell-based and in vivo genome editing research.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":250,"parentId":239,"title":251,"subTitle":13,"excerpt":252,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},36,"sgRNA library","CRISPR sgRNA libraries support high-throughput functional genomics screening by linking gene perturbation to phenotypic analysis for target discovery and validation.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":21,"title":9,"excerpt":7,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"sort":7,"createDate":7,"secondColor":7,"showOrderPic":7,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"serviceFeatureList":7,"productServiceSubList":254},[255,256],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":100,"parentId":21,"title":101,"subTitle":13,"excerpt":13,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":34,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":104,"parentId":21,"title":105,"subTitle":13,"excerpt":13,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":82,"title":258,"excerpt":7,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"sort":7,"createDate":7,"secondColor":7,"showOrderPic":7,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"serviceFeatureList":7,"productServiceSubList":259},"Recombinant Protein",[260,264,268,272,276],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":261,"parentId":82,"title":262,"subTitle":13,"excerpt":263,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":162,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},23,"Cell Free Expression","GenCefe offers a cell-free protein expression system for proteins that are difficult to express in conventional systems, including membrane proteins, toxic proteins, and proteins requiring non-standard amino acids.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":265,"parentId":82,"title":266,"subTitle":13,"excerpt":267,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},38,"Bacterial Expression","GenCefe provides E. coli–based protein expression services with optimization of gene design, vectors, fusion tags, and expression conditions to improve protein yield and solubility.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":269,"parentId":82,"title":270,"subTitle":13,"excerpt":271,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},53,"Mammalian Cell Expression","GenCefe’s mammalian expression systems (CHO and HEK293) produce recombinant proteins and antibodies with proper post-translational modifications for functionally relevant applications.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":273,"parentId":82,"title":274,"subTitle":13,"excerpt":275,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},54,"Insect Cell\u002FBaculovirus Expression","The insect cell\u002Fbaculovirus system enables eukaryotic protein expression with complex folding and post-translational modifications, suitable for research and development use.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":89,"parentId":82,"title":277,"subTitle":13,"excerpt":278,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},"Yeast Expression","Yeast-based expression systems provide a cost-effective option for recombinant protein production, supported by sequence and expression optimization strategies.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":280,"title":281,"excerpt":7,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"sort":7,"createDate":7,"secondColor":7,"showOrderPic":7,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"serviceFeatureList":7,"productServiceSubList":282},7,"Peptide Synthesis & Modification",[283,287,291,295,299,303,307],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":284,"parentId":280,"title":285,"subTitle":13,"excerpt":286,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},19,"Custom Peptide Synthesis","GenCefe Biotech uses solid- and liquid-phase peptide synthesis to deliver high-quality custom, modified, labeled, cyclized peptides, glycopeptides, and libraries.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":288,"parentId":280,"title":289,"subTitle":13,"excerpt":290,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},18,"Modified\u002FFluorescent Labeled Peptides","GenCefe provides over 300 different peptide modification groups, including: N-\u002FC-terminal modifications, fluorescent labeling, cyclic peptides, biotin labeling, etc.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":292,"parentId":280,"title":293,"subTitle":13,"excerpt":294,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},17,"Stable Isotope-Labeled Peptides","GenCefe offers custom stable isotope-labeled peptides by incorporating isotope-labeled amino acids like C and N directly during synthesis, labeling the entire peptide chain.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":296,"parentId":280,"title":297,"subTitle":13,"excerpt":298,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},44,"Cyclic Peptide Synthesis","GenCefe Biotech provides clyclic peptide synthesis services, including Stapled Peptides, Cyclization at side chain, Head-to-tail cyclization, etc.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":300,"parentId":280,"title":301,"subTitle":13,"excerpt":302,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},45,"Glycopeptides","GenCefe Biotech provides glycosylation modification services, producing glycopeptides with N-linked and O-linked types to enhance protein stability, activity, and cell signaling.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":304,"parentId":280,"title":305,"subTitle":13,"excerpt":306,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},46,"Peptide Libraries","GenCefe Biotech provides a variety of peptide library synthesis services, including over lapping libraries, random libraries, amino acid scanning libraries, etc.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":308,"parentId":280,"title":309,"subTitle":13,"excerpt":310,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":162,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},47,"Catalog Peptides","GenCefe Biotech offers over 2,000 catalog peptides covering popular research areas, available from stock.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":70,"title":312,"excerpt":7,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"sort":7,"createDate":7,"secondColor":7,"showOrderPic":7,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"serviceFeatureList":7,"productServiceSubList":313},"Synthetic DNA Libraries",[314,318,322,326,330],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":315,"parentId":70,"title":316,"subTitle":13,"excerpt":317,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},30,"Site-Directed Mutagenesis Libraries","Site-directed mutagenesis libraries introduce defined amino acid substitutions at selected positions, enabling structure–function studies, protein engineering, and antibody optimization.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":319,"parentId":70,"title":320,"subTitle":13,"excerpt":321,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},21,"Random Mutagenesis Libraries","Random mutagenesis libraries generate diverse sequence variants through random nucleotide mutations, making them ideal for directed evolution and functional discovery.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":323,"parentId":70,"title":324,"subTitle":13,"excerpt":325,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},31,"Degenerate (Saturation Mutagenesis) Libraries","Degenerate (saturation mutagenesis) libraries introduce NNK or NNN codons at selected positions to generate broad amino acid diversity for protein engineering and affinity maturation.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":327,"parentId":70,"title":328,"subTitle":13,"excerpt":329,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},32,"Controlled (Trimer) Libraries","Controlled (Trimer) libraries use predefined trinucleotide building blocks to precisely control amino acid diversity while reducing codon redundancy for efficient library design.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":331,"parentId":70,"title":332,"subTitle":13,"excerpt":333,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"sort":7,"hotState":5,"newState":5,"type":102,"customerTestimonials":7,"productCatalog":7,"relatedTitles":7,"productService":7,"customerTestimonialsList":7,"relatedTitlesList":7,"serviceFeatureSubList":7,"productCatalogList":7},33,"CRISPR sgRNA Libraries ","CRISPR sgRNA libraries enable high-throughput functional screening for target discovery, functional genomics, and phenotype-based studies.",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"id":19,"title":335,"excerpt":7,"content":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"sort":7,"createDate":7,"secondColor":7,"showOrderPic":7,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"serviceFeatureList":7,"productServiceSubList":336},"Reagents & Kits",[],{"msg":4,"code":5,"data":338},[339,347,351,354,357,359],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"parentName":7,"parentId":5,"orderNum":7,"ancestors":7,"id":112,"title":340,"excerpt":7,"content":7,"publishDate":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"productServiceId":7,"sort":341,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"applicationsSubList":342,"productService":7},"Oligonucleotide Drug Synthesis",90,[343,345],{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"parentName":7,"parentId":112,"orderNum":7,"ancestors":7,"id":284,"title":344,"excerpt":7,"content":7,"publishDate":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"productServiceId":7,"sort":341,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"applicationsSubList":7,"productService":7},"Oligonucleotide Synthesis and Modifications",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"parentName":7,"parentId":112,"orderNum":7,"ancestors":7,"id":235,"title":346,"excerpt":7,"content":7,"publishDate":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"productServiceId":7,"sort":136,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"applicationsSubList":7,"productService":7},"Oligonucleotide biological evaluation platform",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"parentName":7,"parentId":5,"orderNum":7,"ancestors":7,"id":348,"title":349,"excerpt":7,"content":7,"publishDate":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"productServiceId":7,"sort":350,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"applicationsSubList":7,"productService":7},14,"Gene&Genome Editing",80,{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"parentName":7,"parentId":5,"orderNum":7,"ancestors":7,"id":352,"title":353,"excerpt":7,"content":7,"publishDate":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"productServiceId":7,"sort":220,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"applicationsSubList":7,"productService":7},15,"Synthetic Biology",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"parentName":7,"parentId":5,"orderNum":7,"ancestors":7,"id":355,"title":356,"excerpt":7,"content":7,"publishDate":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"productServiceId":7,"sort":94,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"applicationsSubList":7,"productService":7},16,"Antibody Drug Discovery",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"parentName":7,"parentId":5,"orderNum":7,"ancestors":7,"id":292,"title":358,"excerpt":7,"content":7,"publishDate":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"productServiceId":7,"sort":136,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"applicationsSubList":7,"productService":7},"IVD Raw Material",{"createBy":7,"createTime":7,"updateBy":7,"updateTime":7,"remark":7,"parentName":7,"parentId":5,"orderNum":7,"ancestors":7,"id":288,"title":360,"excerpt":7,"content":7,"publishDate":7,"seoTitle":7,"seoDesc":7,"seoKeywords":7,"createDate":7,"orderDesc":7,"orderUrl":7,"email":7,"phone":7,"onlineFormUrl":7,"productServiceId":7,"sort":361,"homeState":7,"homePic":7,"homeTitle":7,"homeDesc":7,"homeSort":7,"applicationsSubList":7,"productService":7},"Vaccine and Novel Therapy",40,{"msg":4,"code":5,"data":363},{"companyName":364,"shortCompanyName":365,"title":365,"subTitle":366,"siteUrl":367,"siteDescription":368,"siteKeywords":369,"beiAnInfo":370,"email":96,"phone":97,"address":371},"GENCEFE Biotech (Wuxi, China) ","GenCefe","Your Reliable Partner of Oligo, Gene, Peptide, Protein ","https:\u002F\u002Fwww.gencefebio.com\u002F","GenCefe specializes in DNA, RNA, gene, peptide, and protein synthesis. Combined with our advanced AI-assisted design platform, we provide high-quality services for synthetic biology, molecular diagnostics, and drug discovery.","gene synthesis, oligo synthesis, RNA synthesis, DNA synthesis, peptide synthesis, protein expression and purification, gencefe, gencefe biotech","ICP备案：XXXXXXX\r\n苏公网安备32021402001785号","17800 Castleton St, Ste 665, City of industry, CA 91748, USA"]